<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03709615</url>
  </required_header>
  <id_info>
    <org_study_id>UHaifaCBT</org_study_id>
    <nct_id>NCT03709615</nct_id>
  </id_info>
  <brief_title>Therapeutic Processes in iCBT for SAD</brief_title>
  <official_title>Therapeutic Processes in Internet-Based CBT for Social Anxiety Disorder: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Haifa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hebrew University of Jerusalem</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linkoeping University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Haifa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study examines therapeutic processes during internet-based cognitive-behavioral&#xD;
      therapy for social anxiety disorder. Participants will be randomized to either treatment or&#xD;
      wait-list conditions. Participants in the wait-list condition will receive active treatment&#xD;
      following the wait-list period.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Internet-based cognitive-behavioral therapy (iCBT) is an effective treatment for social&#xD;
      anxiety disorder (SAD). However, little is known about the processes and mechanisms of change&#xD;
      in this treatment. Compared to face to face (FTF) treatments, online interventions may&#xD;
      operate through partially different mechanisms of change due to the text-based nature of the&#xD;
      interaction and the reduced level of therapist involvement. The present randomized controlled&#xD;
      trial will examine therapeutic processes during iCBT for SAD including the presence of sudden&#xD;
      gains and their relationship to outcome, the relationship between anxiety and depressive&#xD;
      symptoms along the course of treatment, changes in the therapeutic alliance and attrition&#xD;
      from therapy. Moreover, we will compare iCBT for SAD with a wait-list control group and&#xD;
      utilize weekly measurements of anxiety, depression, and SAD-related cognitions in both&#xD;
      groups. This will facilitate comparison between temporal processes in both conditions and&#xD;
      also shed light on processes occurring in wait-list conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 20, 2017</start_date>
  <completion_date type="Actual">June 20, 2020</completion_date>
  <primary_completion_date type="Actual">June 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Social anxiety severity</measure>
    <time_frame>Change from Baseline LSAS at post treatment (12 weeks)</time_frame>
    <description>Post treatment Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnosis of SAD based on clinical interview</measure>
    <time_frame>Change from Baseline ADIS diagnosis at post treatment (12 weeks)</time_frame>
    <description>Diagnoses derived from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social anxiety severity</measure>
    <time_frame>Change from Baseline LSAS at 6 months follow-up</time_frame>
    <description>Follow-up Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Social anxiety severity - additional measure</measure>
    <time_frame>Change from Baseline SPIN at post treatment (12 weeks)</time_frame>
    <description>Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social anxiety severity - additional measure</measure>
    <time_frame>Change from Baseline SPIN at 6 months follow-up</time_frame>
    <description>Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Depressive symptoms severity</measure>
    <time_frame>Change from Baseline BDI-II at post treatment (12 weeks)</time_frame>
    <description>Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.</description>
  </other_outcome>
  <other_outcome>
    <measure>Depressive symptoms severity</measure>
    <time_frame>Change from Baseline BDI-II at 6 months follow-up</time_frame>
    <description>Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Social Anxiety Disorder</condition>
  <condition>Social Phobia</condition>
  <arm_group>
    <arm_group_label>Wait list</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait list condition with no active treatment, length of 10 weeks, with weekly measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention- active treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internet delivered CBT for social anxiety disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Internet delivered CBT for social anxiety disorder</intervention_name>
    <description>An internet-based CBT for social anxiety based on a protocol from Andersson et al., 2006:&#xD;
&quot;Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial.&quot;</description>
    <arm_group_label>Intervention- active treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Meeting DSM-5 criteria for social anxiety disorder.&#xD;
&#xD;
          -  Fluency in Hebrew&#xD;
&#xD;
          -  Access to internet&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Substance use disorders&#xD;
&#xD;
          -  Past or present psychosis&#xD;
&#xD;
          -  High levels of suicidality&#xD;
&#xD;
          -  Changes in pharmacological treatment 3 months or less prior to the start of the trial&#xD;
&#xD;
          -  Participation in other psychotherapeutic treatments during the trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Idan M Aderka, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Haifa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Haifa</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.icbt.org.il</url>
    <description>Trial landing page (Hebrew)</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 11, 2017</study_first_submitted>
  <study_first_submitted_qc>October 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>May 9, 2021</last_update_submitted>
  <last_update_submitted_qc>May 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Haifa</investigator_affiliation>
    <investigator_full_name>Idan Moshe Aderka</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Social anxiety disorder</keyword>
  <keyword>iCBT</keyword>
  <keyword>Therapeutic processes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
    <mesh_term>Phobia, Social</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

